Chemical Structure : Eluvixtamab
货号: PC-38818Not For Human Use, Lab Use Only.
Eluvixtamab (AMG 330) is a CD33/CD3 bispecific T-cell engager (BiTE) antibody, shows potent CD33-dependent cytolytic activity in vitro and anti-AML activity in vivo.
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Eluvixtamab (AMG 330) is a CD33/CD3 bispecific T-cell engager (BiTE) antibody, shows potent CD33-dependent cytolytic activity in vitro and anti-AML activity in vivo.
AMG 330 binds with low nanomolar affinity to CD33 and CD3ε of both human and cynomolgus monkey origin.
AMG 330 was highly active against human AML cell lines and primary AML cells in a dose- and effector to target cell ratio-dependent manner.
AMG 330 specifically induced expression of CD69 and CD25 as well as release of IFN-γ, TNF, interleukin (IL)-2, IL-10, and IL-6 in AML cells.
AMG 330 (0.002 mg/kg, i.v.) significantly prolonged survival of immunodeficient mice adoptively transferred with human MOLM-13 AML cells and human T cells.
Isotype: Immunoglobulin scFv-scFv.
Anti-[human CD33 (sialic acid binding Ig-like lectin 3, SIGLEC3, SIGLEC-3, gp67, p67)] and anti-[human CD3E (CD3 epsilon)], monoclonal antibody single chain, bispecific.
分子量 | ||
分子式 | ||
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
1. Krupka C, et al. Leukemia. 2016 Feb;30(2):484-91.
2. Friedrich M, et al. Mol Cancer Ther. 2014 Jun;13(6):1549-57.
3. Krupka C, et al. Blood. 2014 Jan 16;123(3):356-65.
4. Laszlo GS, et al. Blood. 2014 Jan 23;123(4):554-61.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright